V. Zoete

Discipline

Histoire, Philosophie et Sociologie des sciences (5) Psychologie (1) Economies et finances (1) Anthropologie biologique (1)

Type de document

Articles (66) Recensions (9)

Co-auteur

Date

Source

Mot-clé

protéine (29) Human beings (28) Proteins (18) spectacle (17) analyse (17) Example (17) Analysis (17) Structure (16) mutation (15) Receptors (15) Mutation (15) modèle (14) Modeling (14) Cancer (14) Buildings (14) cancer (13) Cancer (13) Molecules (13) Ligands (13) Immunotherapy (13) Models (13) Immunotherapy (13) Drugs--Design (12) Properties (12) Use (12) T cells (11) Cells (11) abords (agglomération) (10) Development (10) Forecasting (10)

Documents écrit par V. Zoete (66) | parle de V. Zoete (0)

Methylation-Based Characterization of a New IDH2 Mutation in Sinonasal Undifferentiated Carcinoma.
S. Burgermeister et al. (13 juin 2024)
Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase.
S. Bibert et al. (10 mai 2024)
Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning.
A. Daina et al. (9 mai 2024)
Combining SiRPα decoy-coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cells.
E. Stefanidis et al. (23 avr. 2024)
Two-Step Covalent Docking with Attracting Cavities.
M. Goullieux et al. (25 déc. 2023)
Attracting Cavities 2.0: Improving the Flexibility and Robustness for Small-Molecule Docking.
U.F. Röhrig et al. (26 juin 2023)
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
J. Racle et al. (13 juin 2023)
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
J. Schmidt et al. (6 juin 2023)
Influenza A virus exploits transferrin receptor recycling to enter host cells.
C. Niu et al. (23 mai 2023)
FOXI3 pathogenic variants cause one form of craniofacial microsomia.
K. Mao et al. (11 avr. 2023)
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
F.S. Krebs et al. (24 févr. 2023)
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
R.R. Maas et al. (17 janv. 2023)
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
U.F. Röhrig et al.
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma.
J.M. Cleary et al. (2 sept. 2022)
Actin assembly requirements of the formin Fus1 to build the fusion focus.
L. Michon et al. (1 juil. 2022)
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
M. Arnaud et al.
The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
M.E. Bragina et al. (12 janv. 2022)
Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1).
U.F. Röhrig et al. (23 déc. 2021)
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.
J. Duraiswamy et al. (13 déc. 2021)
The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies.
V.P. Waman et al. (22 mars 2021)
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
U.F. Röhrig et al. (25 févr. 2021)
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology.
F.S. Krebs et al. (28 oct. 2020)
T-cell repertoire analysis and metrics of diversity and clonality.
J. Chiffelle et al.
Identification of a superagonist variant of the immunodominant Yellow fever virus epitope NS4b214-222 by combinatorial peptide library screening.
A. Bovay et al.
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
M. Graciotti et al. (2 juin 2020)

next